Select Medical Holdings Corporation (SEM)
Jul 1, 2026 - SEM was delisted (reason: acquired by consortium)
16.51
-0.02 (-0.12%)
Inactive · Last trade price on Jun 30, 2026
Select Medical Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5,521 | 5,453 | 5,187 | 4,826 | 4,609 | 6,205 | |
Revenue Growth | 5.79% | 5.12% | 7.48% | 4.70% | -25.71% | 12.16% |
Cost of Revenue | 4,600 | 4,528 | 4,272 | 3,990 | 3,954 | 4,941 |
Gross Profit | 921.02 | 924.8 | 915.54 | 836.47 | 655.59 | 1,264 |
Selling, General & Admin | 457.61 | 449.92 | 507.76 | 435.06 | 407.13 | 491.12 |
Other Operating Expenses | -1.59 | -1.59 | -3.41 | -1.52 | - | -0.33 |
Operating Expenses | 599.18 | 588.63 | 647.22 | 569.23 | 539.29 | 693.43 |
Operating Income | 321.84 | 336.17 | 268.32 | 267.24 | 116.3 | 570.07 |
Interest Expense | -117.21 | -117.94 | -128.61 | -154.17 | -137.47 | -135.99 |
Interest & Investment Income | - | - | - | - | - | 5.35 |
Earnings From Equity Investments | 54.02 | 54.52 | 63.9 | 41.34 | 27.98 | 44.43 |
EBT Excluding Unusual Items | 258.66 | 272.75 | 203.61 | 154.42 | 6.81 | 483.87 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 2.16 |
Legal Settlements | - | - | - | - | - | 19.9 |
Other Unusual Items | - | - | -28.85 | -14.69 | 28.45 | 123.8 |
Pretax Income | 258.66 | 272.75 | 174.77 | 139.72 | 35.27 | 629.72 |
Income Tax Expense | 55.08 | 58.22 | 44.78 | 29.25 | 16.72 | 129.77 |
Earnings From Continuing Operations | 203.58 | 214.53 | 129.99 | 110.47 | 18.55 | 499.95 |
Earnings From Discontinued Operations | - | - | 166.72 | 189.26 | 179.48 | - |
Net Income to Company | 203.58 | 214.53 | 296.7 | 299.73 | 198.03 | 499.95 |
Minority Interest in Earnings | -70.04 | -68.31 | -82.67 | -56.24 | -39.03 | -97.72 |
Net Income | 133.53 | 146.22 | 214.04 | 243.49 | 158.99 | 402.23 |
Preferred Dividends & Other Adjustments | 3.4 | 3.35 | 2.32 | 2.13 | -0.53 | 13.44 |
Net Income to Common | 130.13 | 142.87 | 211.72 | 241.36 | 159.52 | 388.79 |
Net Income Growth | -24.28% | -32.52% | -12.28% | 51.30% | -58.97% | 55.45% |
Shares Outstanding (Basic) | 121 | 123 | 125 | 123 | 125 | 130 |
Shares Outstanding (Diluted) | 121 | 123 | 125 | 123 | 125 | 130 |
Shares Change | -3.15% | -1.58% | 1.23% | -1.22% | -4.32% | 0.36% |
EPS (Basic) | 1.07 | 1.16 | 1.70 | 1.96 | 1.28 | 2.98 |
EPS (Diluted) | 1.07 | 1.16 | 1.70 | 1.96 | 1.28 | 2.98 |
EPS Growth | -21.82% | -31.44% | -13.35% | 53.18% | -57.12% | 54.90% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 152 | 117.24 | 295.69 | 352.86 | 94.45 | 220.69 |
Free Cash Flow Per Share | 1.25 | 0.96 | 2.37 | 2.87 | 0.76 | 1.69 |
Dividend Per Share | 0.250 | 0.250 | 0.438 | 0.500 | 0.500 | 0.500 |
Dividend Growth | -33.33% | -42.86% | -12.50% | 0% | 0% | - |
Gross Margin | 16.68% | 16.96% | 17.65% | 17.33% | 14.22% | 20.36% |
Operating Margin | 5.83% | 6.17% | 5.17% | 5.54% | 2.52% | 9.19% |
Profit Margin | 2.36% | 2.62% | 4.08% | 5.00% | 3.46% | 6.27% |
Free Cash Flow Margin | 2.75% | 2.15% | 5.70% | 7.31% | 2.05% | 3.56% |
EBITDA | 465 | 476.47 | 411.18 | 402.93 | 248.46 | 772.72 |
EBITDA Margin | 8.42% | 8.74% | 7.93% | 8.35% | 5.39% | 12.45% |
D&A For EBITDA | 143.16 | 140.3 | 142.87 | 135.69 | 132.16 | 202.65 |
EBIT | 321.84 | 336.17 | 268.32 | 267.24 | 116.3 | 570.07 |
EBIT Margin | 5.83% | 6.17% | 5.17% | 5.54% | 2.52% | 9.19% |
Effective Tax Rate | 21.30% | 21.34% | 25.62% | 20.94% | 47.42% | 20.61% |